Philip Morris International Operating Cash Flow decreased by 108.5% to -$399.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.0%, from -$350.00M to -$399.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 0.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.63B | $3.87B | $4.03B | $1.12B | $3.52B | $3.07B | $3.09B | -$955.00M | $3.44B | $3.42B | $3.30B | $241.00M | $4.63B | $3.34B | $4.00B | -$350.00M | $3.41B | $4.46B | $4.71B | -$399.00M |
| QoQ Change | — | +6.6% | +4.2% | -72.3% | +215.2% | -12.9% | +0.8% | -130.9% | +460.4% | -0.8% | -3.3% | -92.7% | >999% | -27.8% | +19.7% | -108.7% | >999% | +30.8% | +5.5% | -108.5% |
| YoY Change | — | — | — | — | -2.9% | -20.7% | -23.3% | -185.4% | -2.3% | +11.3% | +6.8% | +125.2% | +34.6% | -2.1% | +21.2% | -245.2% | -26.3% | +33.5% | +17.7% | -14.0% |